M1/M2 polarisation state of M-CSF blood-derived macrophages in systemic sclerosis
Authors: Alain Lescoat, Alice Ballerie, Stephane Jouneau, Olivier Fardel, Laurent Vernhet, Patrick Jego, Valérie Lecureur
Journal: Annals of the Rheumatic Diseases (2018)

M1/M2 polarisation state of M-CSF bloodderived macrophages in systemic sclerosisWe read with interest the work conducted by Soldano and colleagues, 1 exploring M1/M2 macrophage surface markers in circulating blood cells in systemic sclerosis (SSc).Using a wide phenotypic characterisation of circulating cells by flow cytometry, the authors highlight that the percentage of CD14+ cells coexpressing M2 markers (CD206, CD163 and CD204) and M1 markers (TLR4) is higher in patients with SSc than in healthy subjects (HSs).Similarly, CD204+ circulating cells coexpressing M2 markers (CD163, CD206) and M1 markers (TLR4, CD80, CD86) were also over-represented in patients with SSc.][4] However, this study was only conducted on undifferentiated circulating blood cells and the validation of their results on differentiated macrophages is still to be determined.In support of Soldano's results, 1 we present here, a phenotypic analysis conducted on macrophage-colony stimulating factor (M-CSF) resting blood monocyte-derived macrophages (MDM) from glucocorticoid (GC)-free patients fulfilling ACR/EULAR 2013 classification criteria for SSc in comparison with HSs, evaluating the mean of fluorescence intensity (MFI) ratio of six polarisation markers (CD80, CD206, CD204, CD163, CD169 and CD200R1) and supporting the existence of a mixed M1/M2 signature in SSc MDM.In parallel, to assess the value of these markers as 'polarisation markers' in this model of MDM, MDM from HSs were also polarised in vitro into M1 (IFNɣ+LPS), M2a (IL-4 and IL-13) and M2c (IL-10+ dexamethasone). 5 6 Our results confirmed, in HS MDM, the higher expression of CD80 and CD169 in polarised M1 in comparison with M2 and unpolarised/resting M0 subtypes (figure 1A).On the contrary, CD200R1 and CD206 were only overexpressed in HS M2a.The expressions of CD163, usually considered as an M2 marker and of CD204, were significantly higher in HS M2a when compared with HS M1 but were not different from those of HS M0 (figure 1A). 6In SSc M0, CD200R1 and CD204 were significantly decreased in comparison with M0 from HS (figure 1B).The expression of these markers was comparable in SSc M0 and HS M1 (respectively in SSc M0 and HS M1, MFI ratio for CD200R1: 1.83±0.11vs 1.64±0.096;p>0.05 and CorrespondenceFigure 1 Polarisation markers of M-CSF MDMs from patients with SSc and HSs.(A) Primary human blood monocytes from HSs were differentiated into MDM in vitro in the presence of 50 ng/mL of M-CSF for 6 days.At day 6, media were replaced by a fresh media (RPMI with 5% of fetal bovine serum with 10 ng/mL of M-CSF) and MDM were polarised for additional 24 hours by the addition of 20 ng/mL IFNɣ and 20 ng/mL LPS (M1), by 20 ng/mL IL-4 and 20 ng/mL IL-13 (M2a) and by 20 ng/mL IL-10 with 10 nM of dexamethasone (M2c) or unpolarised/resting (M0).Cells were then harvested, stained and the expression of cell surface molecules was analysed on a LSRII Fortessa flow cytometer.Data are expressed as MFI relative to isotype control (ratio)±SEM for at least six independent experiments.ANOVA followed by Newman-Keuls' multiple comparison test, **p<0.01 and ***p<0.001.(B) Primary human blood monocytes from HSs and patients with SSc were differentiated into MDM in vitro in the presence of 50 ng/mL of M-CSF for 6 days.At day 6, media were replaced by a fresh media (RPMI with 5% of fetal bovine serum with 10 ng/mL of M-CSF) for additional 24 hours.These M0 unpolarised/resting cells were then harvested, stained and the expression of cell surface molecules was analysed on a LSRII Fortessa flow cytometer.Data are expressed as MFI relative to isotype control (ratio)±SEM for at least 13 HSs and for 11-16 patients with SSc.Student unpaired t-test, *p<0.05 and **p<0.01.ANOVA, analysis of variance; HSs, healthy subjects; MDM, monocyte-derived macrophages; MFI, mean fluorescence intensity; SSc, systemic sclerosis.